Ortho Regenerative
-
Biologics
Ortho Regenerative Technologies selects US based specialized CRO, MCRA LLC, for its upcoming phase I/II rotator cuff human trial
MONTREAL, Sept. 12, 2019 /CNW/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTI” or the “Company“), an emerging Orthobiologics company, announced today…
Read More » -
Sports Medicine
Ortho Regenerative technology platform front and center at 2017 ORS Annual Meeting
KIRKLAND, QC, March 24, 2017 /CNW Telbec/ – Ortho Regenerative Technologies Inc. (“Ortho RTi” or the “Company”), an emerging Orthopaedic and…
Read More »